Tekla Life Sciences Investors

HQL · NYSE
Analyze with AI
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Assets
Cash & Equivalents$0$0$0$1
Short-Term Investments$17,231$15,242$0$0
Receivables$231$5,045$623$150
Inventory$0$0$0$0
Other Curr. Assets$51-$15,242$0-$7
Total Curr. Assets$282$5,045$624$145
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$460,301$397,529$414,076$534,008
Tax Assets$0$0$0$0
Other NC Assets$13,901$0$0$0
Total NC Assets$474,203$397,529$414,076$534,008
Other Assets-$13,901$26$25$33
Total Assets$460,583$402,600$414,725$534,185
Liabilities
Payables$2$0$5,100$150
Short-Term Debt$0$0$11,092$10,042
Tax Payable$0$0$0$0
Deferred Revenue$0$0$5,089$0
Other Curr. Liab.$887$0-$16,180$553
Total Curr. Liab.$889$0$5,100$10,745
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$887$667$11,723$10,745
Total NC Liab.$887$667$11,723$10,745
Other Liabilities$889$0$6,624-$9,403
Cap. Leases$0$0$0$0
Total Liabilities$889$667$16,823$10,745
Equity
Pref Stock$0$0$0$0
Common Stock$281$268$257$247
Retained Earnings$44,128-$1,481$9,549$150,702
AOCI$0$0$0$0
Other Equity$415,286$403,147$388,097$372,492
Total Equity$459,695$401,934$397,902$523,440
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$460,583$402,600$414,725$534,185
Net Debt$0-$0$11,091$10,041
Tekla Life Sciences Investors (HQL) Financial Statements & Key Stats | AlphaPilot